Signaling pathways
-
BA4602 SibrafibanSummary: Sibrafiban (RO48-3657) is an Ro44-3888 orally active, non-peptide, dual precursor that is a selective glycoprotein IIb/IIIa receptor antagonist. - BA4603 FITC-Ahx-Gly-Arg-Gly-Asp-Ser-ProSummary: FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro is coupled to FITC.
- BA4604 GRGDSPKSummary: GRGDSPK (EMD56574) is a polypeptide containing arginine-glycine-aspartic acid (RGD).
- BA4606 FuzapladibSummary: Fuzapladib (IS-741) is an orally active inhibitor of leukocyte function-related antigen type 1 activation, a leukocyte adhesion molecule.
- BA4607 K34cSummary: K34c is a potent and selective antagonist.
- BA4609 AficamtenSummary: Aficamten (CK-274) is a novel cardiac myosin inhibitor.
- BA4610 DanicamtivSummary: Danicamtiv (MYK-491), an inotropic agent, is a selective denatured activator of cardiac actin.
- BA4611 para-NitroblebbistatinSummary: para-Nitroblebbistatin is a non-cytotoxic, photostable, non-fluorescent, specific inhibitor of myosin II.
- BA4612 PentachloropseudilinSummary: Pentachloropseudilin (AntibioticA15104Y; PCLP) is a reversible, variably potent myosin inhibitor.
- BA4613 ATM-3507Summary: ATM-3507 is a potent inhibitor.